China News Service, November 30 (Reporter Chen Jing) Diabetes combined with retinopathy is one of the main causes of blindness in diabetic patients.
This blindness can actually be prevented.
However, at present, it is an indisputable fact that there is a lack of relevant ophthalmological equipment and doctors.
How to "break the question"?
The reporter learned on the 30th that the 24th National Academic Conference of Diabetes Branch of Chinese Medical Association released online and offline diabetic macular edema (hereinafter referred to as "DME") predictive screening model, which provides a simple, convenient, practical and economical Solutions to facilitate the advancement of screening barriers.
It is understood that doctors can use the "DME prediction model" to make comprehensive judgments based on patient data indicators, such as age, gender, smoking history, diabetes history, insulin, blood pressure, hemoglobin, etc., to predict the risk of macular edema in diabetic patients.
Professor Kuang Hongyu pointed out that early diagnosis and treatment can prevent 90% of diabetic patients from severe vision loss.
Photo courtesy of Diabetes Branch of Chinese Medical Association
Professor Zhu Dalong, chairman of the Diabetes Branch of the Chinese Medical Association, said in an interview on the 30th that according to the assessment of the prediction model, if a patient is likely to suffer from macular edema, doctors can pay attention to the patient in a timely manner, and help the patient to diagnose and treat early .
Professor Xu Xun, head of the Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association, said that diabetic retinopathy is preventable "blindness". If it can be screened and treated early, it can protect the eyesight of patients.
But at the same time, diabetic retinopathy is also irreversible.
"If the disease progresses to an advanced stage, then treatment is very difficult and the recovery will be worse."
Professor Kuang Hongyu, head of the Retinopathy Group of the Diabetes Branch of the Chinese Medical Association, also said that retinopathy is different from other eye diseases and cannot be replaced, and treatment pressure is huge.
For example, she said, for example, the treatment of cataracts can be solved by replacing the lens, but this is not feasible for the treatment of retinopathy.
Diabetic retinopathy is also expensive to diagnose.
Zhu Dalong introduced that nowadays, screening for macular degeneration and macular edema is still difficult, and it is necessary to go through methods such as ophthalmoscope and OTC scanning.
Professor Kuang Hongyu told reporters that fundus screening requires fundus photographs and fundus angiography. If it is suspected that the macula is diseased, further optical coherence tomography (OTC) scans are required. However, many hospitals do not have relevant equipment and lack full-time staff, which is a great Pressures and challenges.
The expert bluntly said that diabetic patients pay less attention to macular edema and are less willing to screen, so the discovery is usually in the late stage.
Professor Kuang Hongyu pointed out that the release of the diabetic macular edema prediction model fills the gap in the early screening of Chinese diabetic retinopathy patients.
Early diagnosis and treatment can prevent 90% of diabetic patients from severe vision loss.
Professor Zhu Dalong said frankly that the "DME prediction model" provides a very simple and convenient early screening program for diabetic patients. It does not rely on ophthalmologists and professional equipment, and can also free patients from pain such as fluorescent photography.
By predicting the patient, the endocrinologist can divert the high-risk patients identified by the screening to the ophthalmology department for further examination and treatment.
During the interview, many experts said that the popularization and use of the DME prediction model will help endocrinologists and ophthalmologists work together to overcome the problem of diabetic retinopathy prevention and treatment, strengthen the comprehensive management of diabetics' fundus complications, and protect people's eye health.
(Finish)